This trial is active, not recruiting.

Condition cardiac arrest
Treatment aspect bis xp (a-2000) bispectral index patient monitor
Sponsor Centre Hospitalier Universitaire de Besancon
Start date August 2012
End date September 2014
Trial size 102 participants
Trial identifier NCT02869997, P/2012/128


The aim of this study is to evaluate the prognostic value of the suppression ratio monitored by Bispectral Index for prediction of neurologic outcome after cardiac arrest. All patient admitted to our intensive care unit after a cardiac arrest are included. The results of the suppression ratio will be collected in the 6 first hours of admission. We will evaluate the link between suppression ratio and cerebral performance category score collected at three months.

United States No locations recruiting
Other Countries No locations recruiting

Study Design

Intervention model single group assignment
Masking open label
Primary purpose diagnostic
arm wherein all patients Suppression Ratio evaluated by BIS will be collected
aspect bis xp (a-2000) bispectral index patient monitor

Primary Outcomes

Cerebral Performance Category score
time frame: 3 months

Eligibility Criteria

Male or female participants at least 18 years old.

Inclusion Criteria: - Adult - Cardiac arrest admitted to the ICU Exclusion Criteria: - Pregnancy

Additional Information

Official title Evaluation of the Prognostic Value of the Suppression Ratio Evaluated by BIS Among Patients Admitted to the ICU for Cardiac Arrest
Principal investigator François Belon, MD
Trial information was received from ClinicalTrials.gov and was last updated in August 2016.
Information provided to ClinicalTrials.gov by Centre Hospitalier Universitaire de Besancon.